Recent Articles from Business Wire

International Scholarship and Tuition Services, Inc. (ISTS), a leading provider of scholarship and education assistance program administration, and Backpack Payment Technologies, Inc. (Backpack), a financial technology company modernizing payments infrastructure within education funding, today announced a strategic partnership to transform how scholarship funds are delivered to universities across the United States.

Aviz Networks, a software-first, AI networking automation stack, and hosted·ai, the GPU commerce platform for AI infrastructure, today announced a partnership integrating Aviz’s AI factory portfolio, including ONES AI, Aviz Service Gateway, AI Parser, and AI NOC, with the hosted·ai platform. The collaboration combines network automation, token-level observability, and agentic AI operations to help neocloud operators deploy and run AI services.

Videa, the most adopted dental AI platform, and ClearDent today announced a new integration and partnership that will bring Videa’s AI-powered dental imaging capabilities directly into ClearDent, giving Canadian dental professionals access to AI-assisted radiographic insights within the software they already use to manage patient care.

Global, active asset manager Lord Abbett today unveiled a new brand and visual identity that better reflects the firm it has become and where it is headed.

Knightscope, Inc. (NASDAQ: KSCP) (the “Company” or “Knightscope”), the security technology company building the nation’s first Autonomous Security Force, today announced that Signals, the Company’s orchestration software and operational digital twin, is alive in its initial release at Knightscope Headquarters (KHQ), where it maintains a real-time digital twin of the entire site around the clock. Unveiled last month at GSX 2026 in Atlanta as forthcoming technology, Signals has moved from reveal to reality, on schedule.

KinderCare Learning Companies, Inc. (NYSE: KLC) (“KinderCare”), a leading provider of high-quality early childhood education and care, today announced that Tony Amandi, Chief Financial Officer, will participate in one-on-one investor meetings at J.P. Morgan’s 2026 Ultimate Services Investor Conference on November 17, 2026.

Paradromics Inc., a neurotechnology company developing high-data-rate brain-computer interfaces to restore and enhance human capabilities, today announced a collaboration with Siemens Healthineers to develop an advanced multimodal imaging platform designed to support the growing clinical use of implantable brain-computer interfaces (BCIs).

Today DCX Liquid Cooling Systems announced worldwide’s first CDU system with built-in coolant control and treatment system. DCX integrated this coolant quality feature into it’s Facility Coolant Distribution Units: a family of 5-8 MW capable hyperscale-class coolant Distribution Units.

Blackstone (NYSE: BX) today announced the final close of Blackstone Energy Transition Partners V (“BETP V”) at $8.7 billion – more than 50% larger than its predecessor vehicle. The significantly oversubscribed fund reached its hard cap and builds on the strong performance of the strategy’s prior vintages.

Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its HIV and antiviral research and development programs at IDWeek 2026, taking place October 21-24 in Washington, D.C. The 28 presentations, including two oral presentations, will feature research in HIV treatment, HIV prevention and new insights into broader experiences of people living with HIV, as well as emerging antiviral programs.

o9 Solutions, a leading software company powering enterprise planning and decisioning across 30-plus industry verticals with its AI-powered Enterprise Brain platform, today reported the most successful quarter in Company history marked by record Q3 and year-to-date bookings, and its largest-ever aim10x Americas event. The milestone quarter, anchored by a wave of landmark client wins, reflects accelerating enterprise adoption of o9's APEX Decisioning Model and breakthrough Neurosymbolic AI innovations within the o9 Enterprise Brain platform.

Kerrigan Advisors was pleased to represent Fields Auto Group, one of the largest privately-held dealership groups in the US, in the sale of Fields Mazda and Chrysler Dodge Jeep Ram of Asheville, North Carolina. The sale represents Kerrigan Advisors’ 455th franchise sold since the firm’s founding in 2014 and its 149th franchise sold in the South, as well as the firm’s second announced transaction in the Carolinas market this year.

STARTEEPO SICAV a.s. (“STARTEEPO”), which beneficially owns 7.34% of Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQ: XRX) in stocks and options, today issued the following letter to the Xerox Board of Directors (the “Board”):

Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (Nasdaq: INMD), today issued an open letter to all InMode stakeholders. The full text of the letter is below.

Universal Aviation today unveiled its new global brand, Affinity℠ Aviation, marking a major new chapter for a business rooted in more than 65 years of business aviation experience. Say hello to Affinity Aviation.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2026, before the market opens on Thursday, October 29, 2026, and will host a conference call at 8:30 AM ET that day to discuss those results.

Xnode today announced Cortx Sentinel, a new capability of the Xnode Cortx AI Control Plane that checks AI agent actions before they run. Agents that stay within policy earn more autonomy; those that don’t are restricted. Xnode Cortx is now available on AWS, Microsoft Azure and Google Cloud marketplaces.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction (FGR) and acute ischemic stroke, today announced that its virtual key opinion leader (KOL) event, previously scheduled for October 23, 2026, will now be held on Tuesday, November 24, 2026, at 8:00am Eastern Time.

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced its entry into a definitive agreement to acquire Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company headquartered in London, UK, focused on pioneering the design and development of siRNA (short interfering RNA) therapies in areas of high unmet need.

Scienaptic AI, a global leader in AI powered credit decisioning technology, announced today that APG Federal Credit Union (APGFCU) has gone live on its AI platform. This deployment is automating the credit union's lending operations, delivering faster loan decisions, and responsibly expanding fair access to credit for its members. Importantly, all these advancements have been achieved while ensuring fairness, inclusivity, and compliance with regulatory standards, which are integral to the Scienaptic AI platform.

Archer Aviation (NYSE: ACHR) today announced that its all-electric Midnight air taxi completed several days of piloted flights in the Bay Area as part of the company’s ‘No Roads’ flight tour. The flights included multiple trips around the San Francisco Bay, taking off and landing at Oakland International Airport.

Blackhawk Network (BHN), a global branded payments leader, today released new research surveying 694 U.S. business leaders responsible for incentives, commerce and branded payments, finding that artificial intelligence could fundamentally change how consumers discover, select and purchase gift cards. The findings are pertinent as businesses prepare for a future where AI assistants will act on a shopper’s behalf.

Altimetrik, an AI engineering company, has opened a Healthcare & Life Sciences Center of Excellence (CoE) in Hyderabad, India, to accelerate AI innovation for its clients. Its first launch is PharmaOS, Altimetrik’s agentic AI framework for life sciences, built on Altimetrik’s ALTi AIOS™ operating system, which takes clients from a defined use case to a validated, governed AI agent in one week. More offerings will be built alongside clients across the industry.

Genetix Biotherapeutics Inc., the commercial leader in genetic medicine for rare disease with a focus on hematology, today announced the appointment of Meredith Manning as Chief Commercial Officer. Ms. Manning will lead commercial strategy and execution for the company’s portfolio of FDA-approved one-time gene addition cell therapies.

Mattel, Inc. (NASDAQ: MAT) today announced the appointment of Peter Griffith as Chief Financial Officer, effective October 20, 2026. Griffith succeeds Paul Ruh, who will serve in an advisory role through the end of the year to support an effective transition. Griffith will report to Roger Lynch, Chairman and Chief Executive Officer of Mattel, and will also join the company’s board of directors.

Silence Therapeutics plc (Nasdaq: SLN) (“Silence”), a biotechnology company developing precision engineered medicines using its proprietary siRNA technology, today announced that it has entered into a definitive agreement with Merck KGaA, Darmstadt, Germany, pursuant to which Merck KGaA, Darmstadt, Germany has agreed to acquire Silence in an all-cash transaction with an enterprise value of $1.1 billion and an equity value of approximately $1.3 billion, subject to the satisfaction of customary closing conditions.

As prices on many goods and services continued to climb, people kept spending through the end of summer, according to the Q3 2026 SoFi Tech Solutions Debit Spend Index. Debit spend rose 7.4% and transactions rose 5.9% from Q2 to Q3, and every recurring category grew on both measures. More than 62% of debit transactions in the quarter were digital.

As passkeys, verifiable digital credentials and wallet ecosystems move into real-world deployment, organizations are working through how these technologies fit within existing customer journeys, security requirements and technology environments.

BayMark Health Services (“BayMark” or the “Company”), a trusted leader in substance use disorder treatment and recovery services throughout North America, today announced it has successfully finalized a strategic transaction with its existing lenders (the “Transaction”). The Transaction has unanimous support across its capital structure, materially strengthens the Company’s balance sheet, and provides the Company with growth capital. This strengthened financial foundation complements the Company’s robust operating performance and provides a clear path forward for long-term stability and sustainable growth. As a result of the Transaction, BayMark is now significantly better positioned to continue providing its best-in-class substance use disorder treatment to over 70,000 patients every day.

Marqeta (NASDAQ: MQ), the modern card issuing platform, announced today that it is enabling the Square Credit Card, Square's business credit card for sellers, backed by the American Express® Network. With the migration to Marqeta, Square is consolidating its debit, prepaid, and credit programs onto one modern card issuer processor, reducing operational complexity and enabling Square to bring new credit features to market more quickly. Marqeta’s portfolio migration capabilities enable Square to migrate existing accounts and card credentials to Marqeta without disrupting the cardholder experience.

Reliance Medicare Advisors aims to simplify the Medicare Advantage shopping and plan-comparison experience for the 2027 Medicare Annual Enrollment Period (AEP), which runs through December 7, 2026.

SkyMark Companies, a leading manufacturer of aircraft refueling trucks and hydrant dispensers as well as other transportation-related specialty vehicles, and Rampmaster, a premier manufacturer of aircraft refueling solutions for commercial and general aviation market, launch a new world-class aviation refueler that combines shared technical innovation, intellectual property, and engineering expertise from both industry-leading companies to best serve aviation customers.

Dynex Capital, Inc. (NYSE: DX; "Dynex" or the "Company"), a REIT with a long track record of generating dividends from high-quality mortgage assets, reported its third quarter financial results today. Management will host a call today at 10:00 a.m. Eastern Time to discuss the results and business outlook. Details to access the call can be found below under "Earnings Conference Call."

More than 8,000 children urgently need humanitarian assistance following the Panama earthquake.

Longview Research Partners (LRP), an investment management firm on the leading edge of evidence-based investing products, announces its hiring of Alec Messino as the firm’s first ETF Growth Lead as the firm continues to innovate in the ever-expanding ETF space.

Element Biosciences, Inc. today announced the first shipment of Cytos™, a first-of-its-kind multiomics workflow that captures guide RNA, cell morphology, protein expression, and whole transcriptome from the very same single cell in a single run. Screening has always forced a trade-off: researchers could choose between either rich imaging data or deep molecular data, but never from the same cell at the same moment. Cytos eliminates that trade-off, generating a complete, multimodal picture of a cell's biology that has not been achievable before.

Westwin Elements, America’s only Class 1 nickel refinery, and Traxys, a leading global physical trader and merchant in metals and natural resources, today announced agreements under which Westwin may extend its existing feedstock and nickel offtake arrangements with Traxys for a total term of up to 22 years. The amended and restated agreements give Westwin a long-term pathway to secure feedstock and offtake as it expands its U.S. production, reducing commercial risk while strengthening the domestic nickel supply chain.

Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government-regulated industries, today announced that it has completed the acquisition of Gooch & Housego PLC (“G&H” or the “Company”), a global leader in the design and manufacturing of advanced photonic and optical components and subsystems serving the aerospace & defense, industrial and life sciences markets.

Incident IQ, the leading workflow management platform built exclusively for K–12 school districts, today announced the latest product enhancements to iiQ Facilities. More than 860 districts and independent schools already use the iiQ Facilities platform, which has processed over 3.1 million work orders since 2025. The new enhancements improve preventive maintenance efforts, empower facilities teams to resolve issues faster, and meet the realities of busy technicians and staff working across sprawling campuses and distributed facilities.

Latigo Peak Partners (“Latigo Peak”), an independent wealth management firm serving ultra-high-net-worth individuals and families, today announced its official launch with approximately $18.6 billion in assets under management and a team of 48 professionals.

Once Upon a Farm, PBC (NYSE: OFRM), a leading high-growth company driving systemic improvement in childhood nutrition, today announced the appointment of Scott Morris, Co-Founder of Freshpet, to its Board of Directors effective immediately. Morris brings over three decades of expertise and leadership in building and scaling a fresh, refrigerated food brand. At Freshpet (NASDAQ: FRPT), he drove the company’s growth into a category leader with more than $1billion in annual sales.

Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced that it has been awarded an $8 million grant from the California Institute for Regenerative Medicine (CIRM) to support the ongoing first-in-human clinical trial of EPI-321, the company’s lead investigational epigenetic therapy for facioscapulohumeral muscular dystrophy (FSHD).

Del Monte Foods North America, part of Del Monte Corporation, is adding even more flavor to the center-of-store vegetable aisle with the launch of two new canned vegetable offerings: Del Monte® Ranch Flavored Whole Kernel Corn, created in collaboration with Hidden Valley™ Ranch, and Del Monte® Zesty Italian Inspired Vinaigrette Cut Green Beans. The new products expand Del Monte’s portfolio of bold-flavored canned vegetables, developed to meet growing demand for convenient, easy-to-prepare foods that deliver both flavor and value. As more consumers cook and eat at home, especially younger households seeking familiar tastes with a unique twist, Del Monte is making it easier to turn everyday vegetables into craveable sides, snacks and recipe starters.

Stellar Cyber, an open and agentic Integrated Security Operations Center (ISOC) platform, announced today that MarketsandMarkets has recognized the company as a Progressive Company in the AI Security Operations Center market.

Global apparel icon Wrangler® introduces Hay Away™, a groundbreaking bonded sherpa technology engineered to bring practical purpose to a fall favorite. Built to prove that warm, high-pile fleece does not have to carry the outdoor mess home, Hay Away™ delivers the plush comfort and insulation of traditional sherpa while actively repelling hay, straw, mulch, and grass.

Schwab Asset Management®, the asset management arm of The Charles Schwab Corporation, today announced the launch of the Schwab International Bond ETF (NYSE: SCIN), a new low-cost ETF designed to give investors a straightforward way to access the international investment-grade bond market. With an expense ratio of 0.06%, SCIN is one of the lowest-cost ETFs in both the Morningstar Global Bond-USD Hedged and Lipper International Income Funds categories. The first day of trading is expected to be on or about October 21, 2026.

H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world’s largest pureplay adhesives company, today announced that following a thorough review supported by independent financial and legal advisors, its Board of Directors has unanimously rejected Ancora’s second unsolicited, non-binding proposal to acquire its Building Adhesive Solutions (“BAS”) business for between $1.2 billion and $1.4 billion in cash.

Zendesk today introduced Employee Service AI Agents and Advanced Action Flows to resolve complex employee requests from end to end—helping employees get back to work faster and enabling IT, HR, and workplace teams to deliver better outcomes with less administrative effort.

Innoviva Specialty Therapeutics (IST), a subsidiary of Innoviva, Inc. (NASDAQ: INVA), announced today it will present data from four abstracts at IDWeek 2026, the annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS). The meeting will be held October 21–24, 2026, at the Walter E. Washington Convention Center in Washington, D.C.

Angel Oak Capital Advisors, LLC, an investment management firm specializing in value-driven, multi-sector credit investing today announced reverse share splits for three of its ETFs, as detailed below. The reverse splits will not change the total value of a shareholder’s investment.

LexisNexis® Legal & Professional, a global leader in information, analytics, and AI-powered workflow solutions, today announced the launch of Intelligize+ AI™ Disclosure Management Suite, a new set of capabilities that helps disclosure, legal and financial reporting professionals move from researching disclosure to developing, reviewing and validating the filing itself. Teams can bring their own drafts into Intelligize+ AI, analyze them alongside authoritative SEC content and keep the evidence behind each conclusion connected through review, working more efficiently with greater confidence that key disclosure considerations have been addressed.

FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, today announced that the new EB-840S and EB-840T bronchoscopes join Fujifilm’s growing portfolio of advanced pulmonary solutions designed to support visualization, access, and procedural versatility. The new models expand Fujifilm’s bronchoscopy portfolio and are powered by the ELUXEO® Endoscopic Imaging System, featuring LED multi-light technology designed to support enhanced visualization. Both bronchoscopes will be publicly demonstrated at the 2026 American College of Chest Physicians (CHEST) annual meeting in booth 827, October 19-21 in Phoenix, Arizona.

Keepit, the vendor-independent SaaS data protection company, today announced its presence at the Gartner IT Symposium/Xpo™ 2026 and Gartner IT Infrastructure, Operations & Cloud Strategies Conference 2026 in the Americas and Europe this fall.

Madison Capital Group, a vertically integrated real estate investment and development firm, has named Chris Best managing director to lead its expansion into the registered investment advisor (RIA) and family office channels, expanding the firm's distribution of alternative real estate investment strategies.

Evercore announced today that John Vaske has joined the firm as a senior managing director in its chemicals investment banking group. He will be based in New York.

Accenture Federal Services, a subsidiary of Accenture (NYSE: ACN), and Google Public Sector today announced the deployment of Gemini launchpads, a new capability designed to help federal agencies move more quickly from agentic experimentation to mission execution at scale.

PHINIA Inc. (NYSE: PHIN), a diversified industrial supplier and global leader in the development of fuel systems, electrical systems, and aftermarket solutions, announced today that it will participate in Gabelli’s 50th Annual Automotive Symposium on Monday, November 2, 2026. Conference participation will be in-person and include a Q&A session to discuss dynamics across the various markets PHINIA serves around the world and the Company’s business.

Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that it will present preclinical data at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain.

VSBLTY Groupe Technologies Corp. (CSE: VSBY) (OTCQB: VSBGF) (Frankfurt: 5765), a leading provider of AI computer vision and multi-sensor data fusion, today announced production delivery of an AI edge computing platform co-developed with AirBrij Technology under a Joint Development Agreement (“JDA”). VSBLTY Edge eliminates cloud dependency for real-time threat detection, surveillance analytics, and operational intelligence in law enforcement, smart city, and defense environments.

Aramark (NYSE:ARMK), a global leader in food and facilities management, announced that it will host a conference call to review its fourth quarter and full year fiscal 2026 results on Monday, November 16, 2026 at 8:30 a.m. ET. A news release containing the results will be issued before the call.

Nuveen Private Capital, comprised of two leading U.S. and European asset managers Churchill Asset Management (“Churchill”) and Arcmont Asset Management (“Arcmont”), today announced it has surpassed $100 billion in committed capital,1 marking a significant milestone in the platform’s growth.

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, plans to release its third quarter 2026 financial results via its regularly scheduled Form 10-Q filing with the Securities and Exchange Commission (“SEC”). The company also plans to disclose certain non-GAAP financial measures and their reconciliation to their comparable GAAP measures for the third quarter 2026, which will be disclosed in a Form 8-K filing to be filed on the same day as the Form 10-Q. During the pendency of the previously announced acquisition by Sun Pharmaceutical Industries Limited on April 26, 2026, Organon has suspended its quarterly earnings calls.

AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, welcomes the Letter of Intent signed by its mobile network operator partners Deutsche Telekom, Orange, Telefónica and Vodafone to explore a potential joint bid for Mobile Satellite Services (MSS) spectrum as AST SpaceMobile continues to advance service readiness across Europe.

As National Retirement Security Month puts a spotlight on Americans’ financial preparedness for retirement, new research from Longbridge Financial finds a significant confidence divide among older homeowners, with those ages 55 to 64 reporting the lowest retirement confidence across every measure surveyed.

ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced it has secured $36 million in financing led by Catalio Capital Management, a leading innovative healthcare and AI investment firm, with continued support from Baheal, ZAP’s strategic partner in China. The financing reflects strong investor confidence in ZAP’s technology, commercial momentum, and growth potential for non-invasive robotic therapeutics throughout neuroscience.

Zumigo, Inc., a leader in mobile identity intelligence and fraud prevention, today announced that Zumigo InstaAuth has achieved Full FIDO2 Server Certification from the FIDO Alliance (Certificate No. FA001202600033). The certification brings independently validated, phishing-resistant passkey authentication to the Auth Widget in InstaAuth and IDV Builder, Zumigo's no-code identity verification platform, so businesses can offer customers a sign-in that is fast, familiar, and secure.

NRG Energy, Inc. (NYSE: NRG) today announced that its Board of Directors declared a quarterly dividend on the Company’s common stock of $0.475 per share, or $1.90 per share on an annualized basis. The dividend is payable on November 16, 2026, to stockholders of record as of November 2, 2026.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, will host a webcast on Monday, October 26 at 7:00 a.m. EDT (4:00 a.m. PDT) to discuss results from the Phase 1 Study of XmAb819, an ENPP3 x CD3 T-cell engaging bispecific antibody, in development for patients with advanced clear cell renal cell carcinoma (ccRCC).

Silgan Holdings Inc. (NYSE: SLGN) (“Silgan” or the “Company”), Trivium Packaging B.V. (“Trivium”), and funds affiliated with American Industrial Partners ("AIP") today announced a proposed transaction that will combine Silgan's Metal Containers segment and Food and Beverage Flat Cap Closures businesses with Trivium to create Silgan Metal Containers and Closures (“Silgan MCC”). The combination is a transformational next step that accelerates Silgan’s portfolio evolution and will create a best-in-class global supplier of metal packaging for essential consumer products, with complementary operations principally in North America and Europe.

TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq: TCGX), a special purpose acquisition company (SPAC) sponsored by TCGX, today announced the execution of a definitive business combination agreement that will result in TriGemX Bio becoming a publicly traded company. The combined company will be named “TriGemX Bio, Inc.” (the “Combined Company”) and is expected to trade on Nasdaq under the new ticker symbol "TGEM".

SES AI Corporation (“SES AI,” the “Company,” “we” or “us”) (NYSE: SES), a global leader in the development and manufacturing of AI-enhanced high-performance Li-Metal and Li-ion batteries, today announced that it has completed the ramp up of its drone battery plant in Chungju, Korea, to an annual production capacity of one million NDAA-compliant cells. Driven by stronger than expected customer demand, the Company plans to immediately begin expanding the plant further, to three million NDAA-compliant cells per year by the second quarter of 2027.

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced positive topline results from Part A of its randomized, double-blind, placebo-controlled registration-directed Phase 3 clinical trial (Study ‘304’) evaluating VDPHL01, a proprietary, extended-release oral minoxidil formulation, in over 500 males with mild-to-moderate pattern hair loss. These positive registration-directed results, combined with previously reported positive topline findings from Part A of the company’s Phase 2/3 clinical trial (Study ‘302’), position VDPHL01 to potentially become the first FDA-approved oral pill in nearly 30 years for pattern hair loss and a potential best-in-indication treatment option for the 50 million men with pattern hair loss in the U.S. To date, 6-month placebo-controlled data has been reported for more than 1,000 participants in registration-directed studies of VDPHL01 for the treatment of male pattern hair loss.

AstraZeneca advances its ambition to revolutionize cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, October 23-27, 2026.

Taiho Oncology, Inc. and Cullinan Therapeutics, Inc. (Nasdaq: CGEM) today announced results from Cohort C of the Phase 2 REZILIENT2 trial evaluating zipalertinib monotherapy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations or other uncommon EGFR mutations and active central nervous system (CNS) metastases. The data will be presented at the European Society for Medical Oncology (ESMO) Congress 2026, October 23-27, in Madrid, Spain.

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the initiation and opening of clinical trial sites of a multiregional Phase II study of ivonescimab, a novel, potential first-in-class investigational PD-1 / VEGF bispecific antibody, in previously untreated advanced clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer. The study (SMT112-216 / AK112-216 / NCT07877194) is being conducted in collaboration with Summit’s partner, Akeso Inc.